Do fully automated immunoassays for the evaluation of the immune response to SARS-CoV-2 are commutable?

On December 30, 2019, the city of Wuhan, China, experienced an outbreak of unexplained pneumonia. From January 7, 2020, a new betacoronavirus, severe acute respiratory syndrome coronavirus was identified (SARS-CoV-2). The World Health Organization (WHO) has since declared a pandemic with millions of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mairesse, A., Gruson, D., Scohy, A., Kabamba, B., Rodriguez-Villalobos, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089029/
https://www.ncbi.nlm.nih.gov/pubmed/33969166
http://dx.doi.org/10.1016/j.plabm.2021.e00224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089029/
https://www.ncbi.nlm.nih.gov/pubmed/33969166
http://dx.doi.org/10.1016/j.plabm.2021.e00224

Ejemplares similares